Sustained zidovudine treatment on hematopoiesis in immunodeficient mice
- 31 August 1993
- journal article
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 15 (6) , 673-681
- https://doi.org/10.1016/0192-0561(93)90140-t
Abstract
No abstract availableKeywords
Funding Information
- U.S. Department of Veterans Affairs
This publication has 6 references indexed in Scilit:
- Sensitivity of erythroid progenitor colonies to erythropoietin in azidothymidine treated immunodeficient miceBritish Journal of Haematology, 1991
- In vivo toxicity of 3′‐azido‐3′‐deoxythymidine (ALT) on CBA/CA miceThe International Journal of Cell Cloning, 1990
- 3′‐Azido‐3′‐deoxythymidine (AZT) inhibits proliferation in vitro of human haematopoietic progenitor cellsBritish Journal of Haematology, 1988
- Developmental Therapeutics and the Acquired Immunodeficiency SyndromeAnnals of Internal Medicine, 1987
- Toxicity of 3'-azido-3'-deoxythymidine and 9-(1,3-dihydroxy-2-propoxymethyl)guanine for normal human hematopoietic progenitor cells in vitroAntimicrobial Agents and Chemotherapy, 1987
- Suppression of mouse viraemia and retroviral disease by 3′-azido-3′-deoxythymidineNature, 1986